Editas Medicine Announces Fourth Quarter and Full Year 2017 Results and Update – Kaplan Herald
|
Editas Medicine Announces Fourth Quarter and Full Year 2017 Results and Update
Kaplan Herald CAMBRIDGE, Mass., March 06, 2018 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (NASDAQ:), a leading genome editing company, today reported financial results for the fourth quarter and full year 2017. The Company also outlined its recent achievements and … |
